The Times, They are a-Changing
Tóm tắt
Từ khóa
Tài liệu tham khảo
Maartens, 2014, HIV infection: epidemiology, pathogenesis, treatment, and prevention, Lancet, 384, 258, 10.1016/S0140-6736(14)60164-1
Rodger, 2013, Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population, AIDS, 27, 973, 10.1097/QAD.0b013e32835cae9c
2010, Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies., Clin Infect Dis, 50, 1387, 10.1086/652283
Smith, 2014, Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration, Lancet, 384, 241, 10.1016/S0140-6736(14)60604-8
Bickel, 2013, End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years, HIV Med, 14, 127, 10.1111/j.1468-1293.2012.01045.x
Roland, 2016, Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls, AIDS, 30, 435
Ahuja, 2002, Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States, J Am Soc Nephrol, 13, 1889, 10.1097/01.ASN.0000019773.43765.BF
Rodriguez, 2003, Determinants of survival among HIV-infected chronic dialysis patients, J Am Soc Nephrol, 14, 1307, 10.1097/01.ASN.0000062963.56513.28
Ragni, 2005, Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease, Liver Transpl, 11, 1425, 10.1002/lt.20534
Subramanian, 2010, MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates, Gastroenterology, 138, 159, 10.1053/j.gastro.2009.09.053
Blumberg, 2013, Human immunodeficiency virus in solid organ transplantation, Am J Transplant, 13, 169, 10.1111/ajt.12109
Stock, 2010, Outcomes of kidney transplantation in HIV-infected recipients, N Engl J Med, 363, 2004, 10.1056/NEJMoa1001197
Roland, 2008, HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes, Am J Transplant, 8, 355, 10.1111/j.1600-6143.2007.02061.x
Stock, 2003, Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study, Transplantation, 76, 370, 10.1097/01.TP.0000075973.73064.A6
Qiu, 2006, HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients, Transplantation, 81, 1658, 10.1097/01.tp.0000226074.97314.e0
Cooper, 2011, Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort, AIDS, 25, 777, 10.1097/QAD.0b013e328344febb
Mindikoglu, 2008, Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database, Transplantation, 85, 359, 10.1097/TP.0b013e3181605fda
Terrault, 2012, Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection, Liver Transpl, 18, 716, 10.1002/lt.23411
Muller, 2015, HIV-positive-to-HIV-positive kidney transplantation—results at 3 to 5 years, N Engl J Med, 372, 613, 10.1056/NEJMoa1408896
Locke, 2014, Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients, Transplantation, 97, 446, 10.1097/01.TP.0000436905.54640.8c
Kucirka, 2016, Induction immunosuppression and clinical outcomes in kidney transplant recipients infected with human immunodeficiency virus, Am J Transplant, 16, 2368, 10.1111/ajt.13840
Miro, 2015, Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update, J Hepatol, 62, 701, 10.1016/j.jhep.2014.10.032
Locke, 2016, Long-term outcomes after liver transplantation among human immunodeficiency virus-infected recipients, Transplantation, 100, 141, 10.1097/TP.0000000000000829
Locke, 2015, A national study of outcomes among HIV-infected kidney transplant recipients, J Am Soc Nephrol, 26, 2222, 10.1681/ASN.2014070726
Hussain, 2011, Lung transplantation in human immunodeficiency virus (HIV): expanding the horizons, Chest, 140, 172A, 10.1378/chest.1119938
Grossi, 2012, Report of four simultaneous pancreas-kidney transplants in HIV-positive recipients with favorable outcomes, Am J Transplant, 12, 1039, 10.1111/j.1600-6143.2011.03906.x
Uriel, 2009, Heart transplantation in human immunodeficiency virus-positive patients, J Heart Lung Transplant, 28, 667, 10.1016/j.healun.2009.04.005
Mgbako, 2013, Allowing HIV-positive organ donation: ethical, legal and operational considerations, Am J Transplant, 13, 1636, 10.1111/ajt.12311
Schold, 2009, Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant, Clin J Am Soc Nephrol, 4, 1239, 10.2215/CJN.01280209
Richterman, 2015, An assessment of HIV-infected patients dying in care for deceased organ donation in a United States urban center, Am J Transplant, 15, 2105, 10.1111/ajt.13308
Sawinski, 2009, Factors associated with failure to list HIV-positive kidney transplant candidates, Am J Transplant, 9, 1467, 10.1111/j.1600-6143.2009.02637.x
Boyarsky, 2011, Estimating the potential pool of HIV-infected deceased organ donors in the United States, Am J Transplant, 11, 1209, 10.1111/j.1600-6143.2011.03506.x
Stock, 2015, A source of treatment for those who were (almost) lost: human immunodeficiency virus-positive to human immunodeficiency virus-positive kidney transplantation—results at 3 to 5 years, Transplantation, 99, 1744, 10.1097/TP.0000000000000893
Durand, 2016, Realizing HOPE: the ethics of organ transplantation from HIV-positive donors, Ann Intern Med, 165, 138, 10.7326/M16-0560
Muller, 2010, Renal transplantation between HIV-positive donors and recipients, N Engl J Med, 362, 2336, 10.1056/NEJMc0900837
Muller, 2015, Transplantation in resource-limited setting: using HIV-positive donors for HIV-positive patients, Clin Nephrol, 83, 39, 10.5414/CNP83S0039
Reardon, 2014, Hopeful act: a rebel transplants organs from HIV-positive donors, Nat Med, 20, 1086, 10.1038/nm1014-1086
Calmy, 2016, HIV-positive-to-HIV-positive liver transplantation, Am J Transplant, 16, 2473, 10.1111/ajt.13824
Hathorn, 2016, HIV-positive-to-HIV-positive liver transplantation, N Engl J Med, 375, 1807, 10.1056/NEJMc1603850
Boyarsky, 2016, From bench to bill: how a transplant nuance became 1 of only 57 laws passed in 2013, Ann Surg, 263, 430, 10.1097/SLA.0000000000001352
Jain, 2002, The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients, Liver Transpl, 8, 841, 10.1053/jlts.2002.34880
van Maarseveen, 2011, Outcomes of kidney transplantation in HIV-infected recipients, N Engl J Med, 364, 683, 10.1056/NEJMc1014114
Tricot, 2009, Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs, Am J Transplant, 9, 1946, 10.1111/j.1600-6143.2009.02684.x
Ison, 2013, Donor-derived infections in solid organ transplantation, Am J Transplant, 13, 22, 10.1111/ajt.12095
Canaud, 2014, The kidney as a reservoir for HIV-1 after renal transplantation, J Am Soc Nephrol, 25, 407, 10.1681/ASN.2013050564
Gathogo, 2016, Impact of tacrolimus compared with cyclosporin on the incidence of acute allograft rejection in human immunodeficiency virus-positive kidney transplant recipients, Transplantation, 100, 871, 10.1097/TP.0000000000000879
Donia, 2010, Potential use of rapamycin in HIV infection, Br J Clin Pharmacol, 70, 784, 10.1111/j.1365-2125.2010.03735.x
Vincenti, 2016, Belatacept and long-term outcomes in kidney transplantation, N Engl J Med, 374, 2600, 10.1056/NEJMoa1506027
Ebcioglu, 2016, Belatacept conversion in an HIV-positive kidney transplant recipient with prolonged delayed graft function, Am J Transplant, 16, 3278, 10.1111/ajt.13923